# Relative Bioavailability DS-1971a Suspension and Tablets and Food Effect on DS-1971a Tablets

> **NCT02266940** · PHASE1 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** DS-1971a suspension
- **DRUG:** DS-1971a tablet

## Key facts

- **NCT ID:** NCT02266940
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2018-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02266940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02266940, "Relative Bioavailability DS-1971a Suspension and Tablets and Food Effect on DS-1971a Tablets". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02266940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*